• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Waldencast plc - Class A Ordinary Share (NQ:WALD)

1.775 +0.035 (+2.01%)
Streaming Delayed Price Updated: 10:39 AM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Waldencast plc - Class A Ordinary Share

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Today 8:26 EST
Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
January 21, 2026
Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare 
From Waldencast plc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
November 24, 2025
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation 
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 12, 2025
First Half Fiscal 2025 Results and Q3 2025 Financial Results Expected to be Reported on November 24, 2025 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 08, 2025
A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Hair* 
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market 
From Waldencast plc
Via GlobeNewswire
News headline image
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
August 19, 2025
 
Via Benzinga
News headline image
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
From Waldencast plc
Via GlobeNewswire
News headline image
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
August 18, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Earnings Scheduled For August 18, 2025 ↗
August 18, 2025
 
Via Benzinga
News headline image
Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
August 18, 2025
 
Via Benzinga
News headline image
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
July 23, 2025
Via ACCESS Newswire
News headline image
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 23, 2025
From Waldencast plc
Via GlobeNewswire
News headline image
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
June 26, 2025
 
Via Benzinga
News headline image
Waldencast Reports Q1 2025 Financial Results
May 13, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
May 06, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast Q1 Preview: Beauty Brand Glow Dims On Soft Margins, Flat Sales ↗
May 06, 2025
WALD is reporting Q1 results on May 13, Telsey Advisory Group expects margin and earnings miss. Analyst Dana Telsey maintains outperform rating. 
Via Benzinga
Topics Earnings
News headline image
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
April 22, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
March 18, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 18, 2025 ↗
March 18, 2025
 
Via Benzinga
News headline image
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
March 11, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast Q4 Earnings Preview: All Eyes On Tariff Impact, Obagi Skincare Brand ↗
March 11, 2025
Waldencast is set to report Q4 earnings, with analysts projecting $81.69M sales. The company expands Obagi globally while mitigating potential tariff impacts. 
Via Benzinga
Topics World Trade
News headline image
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
February 19, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
February 10, 2025
New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion 
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
January 30, 2025
From Waldencast plc.
Via GlobeNewswire
News headline image
Waldencast Announces Participation in the 2025 IMCAS World Congress
January 29, 2025
From Waldencast plc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap